Figure 4.
Mean serum concentrations of galcanezumab (±standard error of the mean) and fold change induction by capsaicin of dermal blood flow from baseline for repeat administration of 150 mg galcanezumab (Days 1, 14, 28, and 42).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.